Scott T. Jackson's most recent trade in Spero Therapeutics Inc was a trade of 20,000 Common Stock done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Spero Therapeutics Inc | Scott T. Jackson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 20,000 | 75,000 (0%) | 0% | 0 | Common Stock | |
| Mural Oncology plc | Scott T. Jackson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 8,637 | 8,637 | - | - | Stock Option (right to buy) | |
| Macrogenics Inc | Scott T. Jackson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 22,000 | 22,000 | - | - | Stock Option (right to buy) | |
| Macrogenics Inc | Scott T. Jackson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2025 | 6,500 | 11,000 (0%) | 0% | - | Common Stock | |
| Macrogenics Inc | Scott T. Jackson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2025 | 6,500 | 0 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Scott T. Jackson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 3,750 | 3,750 | - | - | Restricted Stock Unit | |
| Mural Oncology plc | Scott T. Jackson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 8,462 | 8,462 | - | - | Stock Option (right to buy) | |
| Mural Oncology plc | Scott T. Jackson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 8,462 | 8,462 | - | - | Stock Option (right to buy) | |
| Spero Therapeutics Inc | Scott T. Jackson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 20,000 | 55,000 (0%) | 0% | 0 | Common Stock | |
| Macrogenics Inc | Scott T. Jackson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 16,500 | 16,500 | - | - | Stock Option (right to buy) | |
| Macrogenics Inc | Scott T. Jackson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 6,500 | 6,500 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Scott T. Jackson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 4,500 | 4,500 (0%) | 0% | 0 | Common Stock | |
| Macrogenics Inc | Scott T. Jackson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 4,500 | 0 | - | - | Restricted Stock Unit | |
| GlycoMimetics Inc | Scott T. Jackson | Director | 01 May 2024 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | ||
| Mural Oncology plc | Scott T. Jackson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 15,021 | 15,021 | - | - | Stock Option (right to buy) | |
| GlycoMimetics Inc | Scott T. Jackson | Director | 19 May 2023 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | ||
| Spero Therapeutics Inc | Scott T. Jackson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2022 | 15,000 | 15,000 (0%) | 0% | 0 | Common Stock | |
| Macrogenics Inc | Scott T. Jackson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| GlycoMimetics Inc | Scott T. Jackson | Director | 18 May 2022 | 21,000 | 21,000 | - | - | Stock Option (right to buy) | ||
| Spero Therapeutics Inc | Scott T. Jackson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2021 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
| GlycoMimetics Inc | Scott T. Jackson | Director | 18 May 2021 | 10,500 | 10,500 | - | - | Stock Option (right to buy) | ||
| GlycoMimetics Inc | Scott T. Jackson | Director | 18 May 2021 | 5,250 | 5,250 (0%) | 0% | 0 | Common Stock | ||
| Macrogenics Inc | Scott T. Jackson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Spero Therapeutics Inc | Scott T. Jackson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2020 | 7,500 | 7,500 | - | - | Stock Option (right to buy) |